ALGS · Aligos Therapeutics, Inc. · Congressional Trades
$1.98
-0.18 (-8.33%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our recurring losses from operations and negative cash flows raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 6, 2026
Market Cap
$7.10M
Shares
3.59M
Volume · Nov 12
120.58K
Avg daily vol (3M)
55.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1799448
CUSIP
01626L204
13F (30d)
18 filings
12 filers
Visit website
Investor relations